Peter Atadja - Dec 15, 2022 Form 4 Insider Report for Onconova Therapeutics, Inc. (ONTX)

Role
Director
Signature
/s/ Mark Guerin, Attorney-in-Fact
Stock symbol
ONTX
Transactions as of
Dec 15, 2022
Transactions value $
$0
Form type
4
Date filed
12/19/2022, 05:56 PM
Next filing
Aug 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Stock Option (right to purchase) Award $0 +100K $0.00 100K Dec 15, 2022 Common Stock 100K $0.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest in 3 installments on the anniversary of the grant date: 33% on the first anniversary, 33% on the second anniversary and 34% on the third anniversary.